1-Bromopropane → HCID 22914226, compound
Reaction equation
C(N(C(C)C)[CH:4]([CH3:6])[CH3:5])C.Br[CH2:11][CH2:12][CH3:13].[NH2:14][CH2:15][C:16]1[N:20]=[C:19]([C:21]2[N:22]=[CH:23][N:24]3[C:30]4[CH:31]=[CH:32][S:33][C:29]=4[C:28](=[O:34])[N:27]([CH3:35])[CH2:26][C:25]=23)[O:18][N:17]=1>CN(C)C=O>[CH2:11]([N:14]([CH2:15][C:16]1[N:20]=[C:19]([C:21]2[N:22]=[CH:23][N:24]3[C:30]4[CH:31]=[CH:32][S:33][C:29]=4[C:28](=[O:34])[N:27]([CH3:35])[CH2:26][C:25]=23)[O:18][N:17]=1)[CH2:5][CH2:4][CH3:6])[CH2:12][CH3:13]Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
4 ml (23.4 mmol) of N-ethyldiisopropylamine and 1.1 ml (12 mmol) of 1-bromopropane were added to a solution of 0.6 g (1.9 mmol) of 3-(3-aminomethyl-1,2,4-oxadiazol-5-yl)-5-methyl-5,6-dihydro-4H-imidazo[1,5-a]thieno[2,3-f][1,4]diazepin-6-one in 20 ml of dimethylformamide and the mixture was stirred at 70° for 1 hour. The reaction solution was subsequently evaporated, whereupon the residue was partitioned between methylene chloride and 2N sodium carbonate solution. The aqueous phase was washed three times with methylene chloride. The organic phases were dried with magnesium sulfate, filtered and evaporated. The residue obtained was chromatographed (silica gel, ethyl acetate/methanol 25:1). There were obtained 440 mg (57%) of 3-(3-dipropylaminomethyl-1,2,4-oxadiazol-5-yl)-5-methyl-5,6-dihydro-4H-imidazo[1,5-a]thieno[2,3-f][1,4]diazepin-6-one as a colourless foam, Rf=0.34 (silica gel, ethyl acetate/methanol 25:1).
Workup
- customThe reaction solution was subsequently evaporated, whereupon the residue
- customwas partitioned between methylene chloride and 2N sodium carbonate solution
- washThe aqueous phase was washed three times with methylene chloride
- dry with materialThe organic phases were dried with magnesium sulfate
- filtrationfiltered
- customevaporated
- customThe residue obtained
- customwas chromatographed (silica gel, ethyl acetate/methanol 25:1)
Sources & evidence
- ORD record
- ord-2bc7f1fd86254bb9a93f8ac7af0603dd
- Source dataset
- uspto-grants-1997_09
- Patent number
- US05665718
Reaction notes
Loading…